Hari Deshpande, MD
Interventional Cardiology · New Haven, CTNPI 1447248117
Payments from drug & device makers
Across 292 payments — averaging $4197.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Deciphera Pharmaceuticals Inc.$426K
- Servier Bioinnovation$318K
- PTC Therapeutics, Inc.$212K
- Eisai Inc.$113K
- Boehringer Ingelheim$52K
- Karyopharm Therapeutics Inc.$45K
- plus $60K from 9 others
Across 13 payments — averaging $145.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- PTC Therapeutics, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 85 | $426,063 |
| Servier Bioinnovation | 61 | $318,396 |
| PTC Therapeutics, Inc. | 40 | $212,352 |
| Eisai Inc. | 29 | $113,007 |
| Boehringer Ingelheim | 8 | $51,776 |
| Karyopharm Therapeutics Inc. | 28 | $44,507 |
| Genentech, Inc. | 17 | $21,655 |
| AstraZeneca | 1 | $12,147 |
| Daiichi Sankyo Inc. | 11 | $10,085 |
| Eli Lilly | 2 | $6,470 |
| Springworks Therapeutics, Inc. | 6 | $3,199 |
| Aadi Bioscience, Inc. | 1 | $2,655 |
| Exelixis Inc. | 1 | $1,980 |
| Blueprint Medicines Corporation | 1 | $950 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $568 |
How this compares
$1,225,808 in reported general payments places this provider in the 95th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in New Haven
- Samit ShahNew Haven$584K
- Amit VoraNew Haven$530K
- Michael RemetzNew Haven$153K
- Sameer NagpalNew Haven$152K
- Michael NannaNew Haven$101K
- Michael ChrissoherisNew Haven$24K
- Sophia AltinNew Haven$17K
- Yasin HussainNew Haven$13K
- Brad StairNew Haven$7K
- Chirag ShahNew Haven$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.